Optilume is a urethral balloon coated with paclitaxel (3.5 microgram/mm 2). It is indicated for managing urethral stricture disease in 'adult males'. It is designed to be used as a drug-coated ...
Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis. Investigators in South Korea demonstrated the benefit in a ...
The Optilume device includes a balloon coated with paclitaxel. The Food and Drug Administration (FDA) has approved the Optilume ® Urethral Drug Coated Balloon (DCB) to treat patients with obstructive ...
HealthDay News — A new guideline by the American Urological Association, published in The Journal of Urology, provides a clinical framework for the diagnosis and treatment of male urethral stricture.
A team of surgeons in the University College Hospital (UCH), Ibadan, led by Prof. Olayinka Shittu, has successfully performed an intricate procedure to reconstruct a urethral stricture in a ...
MOBILE, Ala. (WALA) - In today’s Healthy living Jatinder Kumar, M.D., a Urologist with USA Health University Urology, joined us to talk about symptoms, causes, and treatments of ‘Stricture Disease’.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results